MRK

NYSE · Pharmaceuticals

Merck & Co. Inc.

S&P 500 Dow Jones Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$146.87

-0.28 (-0.19%)

As of Sep 20, 9:30 PM ET ·

Analyst Consensus

Buy

Analysts

Very High

Coverage

Buy 26 72%

Hold 10 28%

Sell 0 0%

Price Target

Analyst Price Target +8.4% upside

Low Target $113.44

Average Target $159.27

High Target $183.82

Current Price $146.87

Current
$146.87

Target
$159.27

$113.44 $159.27 avg $183.82

Scenario Analysis

Bear Case

$113.44

-22.8%

Low target

Base Case

$159.27

+8.4%

Avg target

Bull Case

$183.82

+25.2%

High target

Risk/Reward

1.1x

Balanced

Price in Context

52-Week High

$156.92

-6.4% from high

52-Week Low

$77.58

+89.3% from low

50-Day SMA

$109.24

+34.4% vs SMA

200-Day SMA

$90.33

+62.6% vs SMA

RSI (14)

79.1

Overbought

Target vs 52W High

$159.27

+1.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+15.4%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+10.9%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+8.4%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.6%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+176.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-37.9%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+193.9%